Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 5 Neoplasms 4 Head and Neck Neoplasms 3 Melanoma 2 Lung Neoplasms 2 Carcinoma, Squamous Cell 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Solid Tumor, Adult 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma 1 Breast Neoplasms 1 Brain Neoplasms 1 Advanced Solid Malignancies 1

Interventions

Paclitaxel 42 Carboplatin 35 pembrolizumab 25 Surveys and Questionnaires 23 Letrozole 15 Radiotherapy 14 Megestrol Acetate 14 Blood Specimen Collection 14 Bevacizumab 13 olaparib 12 Metformin 12 dostarlimab 10 Indocyanine Green 10 durvalumab 9 Observation 9 Medroxyprogesterone Acetate 9 Cisplatin 9 lenvatinib 8 atezolizumab 8 Early Intervention, Educational 8 Counseling 8 niraparib 7 Sentinel Lymph Node Biopsy 7 Radiation 7 Methods 7 Magnetic Resonance Spectroscopy 7 Lymph Node Excision 7 Hysterectomy 7 Everolimus 7 abemaciclib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Endometrial Neoplasms × Tiragolumab × Clear all

NCT04486352 2026-04-01

EndoMAP

Alliance Foundation Trials, LLC.

Phase 1/2 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡